The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention

Overview

Journal Clin Geriatr Med

Specialty Geriatrics

Date 2022 Nov 20

PMID 36404025

Authors

Simin Mahinrad

Farzaneh Sorond

Philip B Gorelick

Affiliations

Soon will be listed here.

Abstract

One of the most challenging clinical expressions of population aging is cognitive impairment and dementia. Among risk factors for the development of dementia, modifiable vascular risk factors have emerged as contributors to both vascular and nonvascular types of dementia. Epidemiologic studies have been particularly informative in understanding the link between vascular risks and dementia across the life course. We discuss vascular risks for dementia and cognitive impairment and practical management recommendations.

Citing Articles

Young blood-mediated cerebromicrovascular rejuvenation through heterochronic parabiosis: enhancing blood-brain barrier integrity and capillarization in the aged mouse brain.

Gulej R, Nyul-Toth A, Csik B, Patai R, Petersen B, Negri S Geroscience. 2024; 46(5):4415-4442.

PMID: 38727872 PMC: 11336025. DOI: 10.1007/s11357-024-01154-8.

The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact.

Kalaria R, Maestre G, Mahinrad S, Acosta D, Akinyemi R, Alladi S Alzheimers Dement. 2024; 20(6):4290-4314.

PMID: 38696263 PMC: 11180946. DOI: 10.1002/alz.13836.

What will it take to achieve brain health globally?.

Gorelick P, Hainsworth A, Wallin A Cereb Circ Cogn Behav. 2024; 6:100209.

PMID: 38328025 PMC: 10847852. DOI: 10.1016/j.cccb.2024.100209.

What have clinical trials taught us about brain health?.

Lee K, Bae H Cereb Circ Cogn Behav. 2024; 6:100199.

PMID: 38235315 PMC: 10792690. DOI: 10.1016/j.cccb.2023.100199.

References

Lane C, Barnes J, Nicholas J, Sudre C, Cash D, Malone I . Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort. JAMA Neurol. 2019; 77(2):175-183. PMC: 6830432. DOI: 10.1001/jamaneurol.2019.3774. View

Peters R, Yasar S, Anderson C, Andrews S, Antikainen R, Arima H . Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis. Neurology. 2019; 94(3):e267-e281. PMC: 7108807. DOI: 10.1212/WNL.0000000000008732. View

Unger T, Borghi C, Charchar F, Khan N, Poulter N, Prabhakaran D . 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75(6):1334-1357. DOI: 10.1161/HYPERTENSIONAHA.120.15026. View

Cataldo J, Prochaska J, Glantz S . Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis. 2010; 19(2):465-80. PMC: 2906761. DOI: 10.3233/JAD-2010-1240. View

Erickson K, Donofry S, Sewell K, Brown B, Stillman C . Cognitive Aging and the Promise of Physical Activity. Annu Rev Clin Psychol. 2022; 18:417-442. DOI: 10.1146/annurev-clinpsy-072720-014213. View

Marcum Z, Cohen J, Zhang C, Derington C, Greene T, Ghazi L . Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. JAMA Netw Open. 2022; 5(1):e2145319. PMC: 8800076. DOI: 10.1001/jamanetworkopen.2021.45319. View

Gorelick P, Whelton P, Sorond F, Carey R . Blood Pressure Management in Stroke. Hypertension. 2020; 76(6):1688-1695. PMC: 7666043. DOI: 10.1161/HYPERTENSIONAHA.120.14653. View

Williamson J, Pajewski N, Auchus A, Bryan R, Chelune G, Cheung A . Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019; 321(6):553-561. PMC: 6439590. DOI: 10.1001/jama.2018.21442. View

Luchsinger J, Reitz C, Patel B, Tang M, Manly J, Mayeux R . Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007; 64(4):570-5. DOI: 10.1001/archneur.64.4.570. View

10.

Nasrallah I, Pajewski N, Auchus A, Chelune G, Cheung A, Cleveland M . Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. JAMA. 2019; 322(6):524-534. PMC: 6692679. DOI: 10.1001/jama.2019.10551. View

11.

Vemuri P, Lesnick T, Przybelski S, Knopman D, Lowe V, Graff-Radford J . Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. Ann Neurol. 2017; 82(5):706-718. PMC: 5696029. DOI: 10.1002/ana.25071. View

12.

Hachinski V, Einhaupl K, Ganten D, Alladi S, Brayne C, Stephan B . Preventing dementia by preventing stroke: The Berlin Manifesto. Alzheimers Dement. 2019; 15(7):961-984. PMC: 7001744. DOI: 10.1016/j.jalz.2019.06.001. View

13.

Nasrallah I, Gaussoin S, Pomponio R, Dolui S, Erus G, Wright C . Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial. JAMA Neurol. 2021; 78(5):568-577. PMC: 7941253. DOI: 10.1001/jamaneurol.2021.0178. View

14.

Gorelick P, Furie K, Iadecola C, Smith E, Waddy S, Lloyd-Jones D . Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association. Stroke. 2017; 48(10):e284-e303. PMC: 5654545. DOI: 10.1161/STR.0000000000000148. View

15.

Radd-Vagenas S, Duffy S, Naismith S, Brew B, Flood V, Fiatarone Singh M . Effect of the Mediterranean diet on cognition and brain morphology and function: a systematic review of randomized controlled trials. Am J Clin Nutr. 2018; 107(3):389-404. DOI: 10.1093/ajcn/nqx070. View

16.

Mahinrad S, Kurian S, Garner C, Sedaghat S, Nemeth A, Moscufo N . Cumulative Blood Pressure Exposure During Young Adulthood and Mobility and Cognitive Function in Midlife. Circulation. 2019; 141(9):712-724. PMC: 7135652. DOI: 10.1161/CIRCULATIONAHA.119.042502. View

17.

Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R . A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015; 385(9984):2255-63. DOI: 10.1016/S0140-6736(15)60461-5. View

18.

Gorelick P, Sorond F . Cognitive function in SPRINT: where do we go next?. Lancet Neurol. 2020; 19(11):880-881. DOI: 10.1016/S1474-4422(20)30356-2. View

19.

Dolui S, Detre J, Gaussoin S, Herrick J, Wang D, Kurella Tamura M . Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Neurol. 2022; 79(4):380-389. PMC: 8902686. DOI: 10.1001/jamaneurol.2022.0074. View

20.

Power M, Rawlings A, Sharrett A, Bandeen-Roche K, Coresh J, Ballantyne C . Association of midlife lipids with 20-year cognitive change: A cohort study. Alzheimers Dement. 2017; 14(2):167-177. PMC: 5803364. DOI: 10.1016/j.jalz.2017.07.757. View